MARC Record from Library of Congress

LEADER: 02712cam a22003254a 4500
001 2009045879
003 DLC
005 20141022075735.0
008 091104s2010 njua b 001 0 eng
010 $a 2009045879
020 $a9780470243725 (cloth)
035 $a(DNLM)101518868
040 $aDNLM/DLC$cDLC
050 00 $aRC271.R26$bM66 2010
060 10 $aQZ 269$bM751 2010
082 00 $a616.99/40642$222
245 00 $aMonoclonal antibody and peptide-targeted radiotherapy of cancer /$cedited by Raymond M. Reilly.
260 $aHoboken, N.J. :$bWiley,$cc2010.
300 $axxiii, 624 p. :$bill. (some col.) ;$c25 cm.
504 $aIncludes bibliographical references and index.
505 0 $aAntibody engineering : optimizing the delivery vehicle / Diane Milenic -- The radiochemistry of monoclonal antibodies and peptides / Raymond M. Reilly -- The design of radiolabeled peptides for targeting malignancies / Leonard G. Luyt -- Peptide receptor radionuclide therapy in patients with somatostatin receptor-positive neuroendocrine tumors / Martijn van Essen ... [et al.] -- Targeted radiotherapy of CNS malignancies / Michael R. Zalutsky, David A. Reardon, and Darrell D. Bigner -- Radioimmunotherapy for B-cell non-Hodgkin lymphoma / Thomas E. Witzig -- Radioimmunotherapy of acute myeloid leukemia / Todd L. Rosenblat and Joseph G. Jurcic -- Pre-targeted radioimmunotherapy of solid tumors / Robert M. Sharkey and David G. Goldenberg -- Targeted auger electron radiotherapy of malignancies / Raymond M. Reilly and Amin Kassis -- Viral introduction of receptors for targeted radiotherapy / Kathryn Ottolino-Perry and J. Andrea McCart -- Preclinical cell and tumor models for evaluating radio-pharmaceuticals in oncology / Ann F. Chambers ... [et al.] -- Radiation biology of targeted radiotherapy / David Murray and Michael Weinfeld -- Dosimetry for targeted radiotherapy / Sui Shen -- The bystander effect in targeted radiotherapy / Carmel Mothersill and Colin Seymour -- The role of molecular imaging in evaluating tumor response to targeted radiotherapy / Norbert Avril -- The economic attractiveness of targeted radiotherapy : value for money? / Jeffrey S. Hoch -- Selected regulatory elements in the development of cancer targeted protein and peptide radiotherapeutic agents / Thomas R. Sykes and Connie J. Sykes.
650 0 $aCancer$xRadioimmunotherapy.
650 0 $aMonoclonal antibodies$xTherapeutic use.
650 0 $aTumor proteins.
650 12 $aNeoplasms$xradiotherapy.
650 22 $aAntibodies, Monoclonal$xtherapeutic use.
650 22 $aPeptides$xtherapeutic use.
650 22 $aRadioimmunotherapy$xmethods.
650 22 $aReceptors, Peptide$xtherapeutic use.
700 1 $aReilly, Raymond.